Back

Impact of pre-existing vascular disease on clinical outcomes in patients with non-ST-segment myocardial infarction: a nationwide cohort study

26 August 2022 (12:15 - 13:00)
Organised by:
Congress Presentation Part of: Coronary artery disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Nick Weight

Keele University, Stoke-on-Trent (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Serum levels of the endoplasmic-reticulum-stress chaperone GRP78 identify patients with coronary artery disease and predict mortality
Mr M. Al Zaidi (Bonn, DE)
Abstract Slides
Presentation thumbnail
Coronary artery disease is a stronger predictor of mortality than left ventricular ejection fraction among newly diagnosed patients with heart failure
Doctor K. Pryds (Aarhus N, DK)
Abstract Slides
Presentation thumbnail
Using high-sensitivity cardiac troponin for the exclusion of inducible myocardial ischemia in patients without previously known coronary artery disease
Mr I. Schaefer (Basel, CH)
Abstract Slides
Presentation thumbnail
Phosphomimetic Endothelial Nitric Oxide Synthase- loaded microbubbles- mediated cardiac shock wave transfection therapy for angiogenesis in the ischemic myocardium
Doctor H. Mehrad (Tabriz, IR)
Abstract Slides
Presentation thumbnail
High bleeding risk in all-comers with ST-segment elevation myocardial infarction and use of P2Y12-inhibitiors
Miss M. Jacobsen (Copenhagen, DK)
Abstract Slides

Access the full session

Session thumbnail
Coronary artery disease

The Event

Event poster

ESC Congress 2022

26 August 2022 12:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources